Skip to main
  1. Stocks
  2. GE HealthCare Technologies Inc
  3. Forecast
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 22%
Buy 33%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is supported by a diversified, recurring-heavy model, with roughly half of revenue recurring through service, pharmaceutical diagnostics, and digital solutions, while its imaging and ultrasound leadership gives it scale across a $90 billion market. Its outlook is strengthened by healthy capital book-to-bill trends, backlog of $23.9 billion as of 2Q26, and management’s ability to convert growth into earnings through cost discipline, tariff mitigation, and a medium-term operating margin target of 17-20%+. The Sofie Biosciences acquisition for $945 million in cash should further enhance the radiopharmaceuticals portfolio, add a phase 3 asset, and be accretive to revenue growth, operating margin, and EPS in the first full year.

Bears say

GE HealthCare Techs is viewed cautiously because its bear case assumes only low-single-digit revenue growth, which would translate into slower earnings growth and reflects sensitivity to a weak macro backdrop. Hospital capital budget pressure could dampen demand for capital equipment and related services, while China remains a key overhang: revenue mix fell from 15% in 2021 to 11% in 2025 and has been a 60 bps to 140 bps growth headwind since 2021 and 2024. Tariffs and inflation have also pressured execution, with $250 million of tariff impact in 2025 and materially higher inflation, raising concern that cost savings may constrain commercial activity, R&D, and the pipeline.

GEHC has been analyzed by 18 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 33% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

GEHC Analyst Forecast & Price Prediction

Get the latest GEHC stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in GEHC

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 18 analysts, GEHC has a Buy consensus rating as of Oct 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $80.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $80.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


GEHC Analyst Forecast & Price Prediction

Get the latest GEHC stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in GEHC

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover GEHC stock data and trends